Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Precancerous Conditions 20Neoplasms 9Advanced Malignant Neoplasm 9Keratosis, Actinic 8Skin Diseases 5Keratosis 5Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 2Preleukemia 2Pathologic Processes 2Neoplasms by Site 2Neoplasms by Histologic Type 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leukemia 2Hormone Receptor Positive Malignant Neoplasm of Breast 2Hematologic Diseases 2Endometrial Neoplasms 2Carcinoma 2Breast Neoplasms 2Bone Marrow Diseases 2Biochemical Recurrence of Malignant Neoplasm of Prostate 2Uterine Prolapse 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Thrombocythemia, Essential 1Syndrome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Endometrial Hyperplasia × Other neoplasm × Clear all
NCT07544680 2026-04-22

ENVISION

Exact Sciences Corporation

Recruiting
4,200 enrolled
GynecologicOther neoplasm

Endometrial Hyperplasia, Metrorrhagia, Precancerous Conditions, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡